DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1BUPROPION HYDROCHLORIDE
02 1DESVENLAFAXINE SUCCINATE
03 1DIVALPROEX SODIUM
04 1DUTOPROL
05 1ENVARSUS XR
06 1FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
07 1KEPPRA XR
08 1LEVETIRACETAM
09 1METFORMIN HYDROCHLORIDE
10 10METOPROLOL SUCCINATE
11 1ROPINIROLE HYDROCHLORIDE
12 1TOPROL-XL
01 119962
02 121956
03 122285
04 178889
05 190615
06 190617
07 191557
08 1202786
09 1203028
10 1203699
11 1203969
12 1204003
13 1204161
14 1206145
15 1206406
16 1207465
17 1209116
18 1209286
19 1211143
20 1213854
21 1216916
01 19No
02 2Yes
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78889
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 216916
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 204161
Country : US
Patented : No
Drug : LEVETIRACETAM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 91557
Country : US
Patented : No
Drug : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 204003
Country : US
Patented : No
Drug : ROPINIROLE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202786
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 211143
Country : US
Patented : No
Drug : METFORMIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 206145
Country : US
Patented : No
HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE
Drug : DUTOPROL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21956
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213854
Country : US
Patented : No
LOOKING FOR A SUPPLIER?